Company

Torii Pharmaceutical Co. Ltd

Headquarters: Tokyo, Japan

Employees: 568

CEO: Mr. Goichi Matsuda

JPX: 4551 -1.89%

Market Cap

¥105.39 Billion

JPY as of July 1, 2024

US$652.7 Million

Market Cap History

Torii Pharmaceutical Co. Ltd market capitalization over time

Evolution of Torii Pharmaceutical Co. Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Torii Pharmaceutical Co. Ltd

Detailed Description

Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; allergen immunotherapy tablets comprising CEDARCURE and MITICURE; and CEDARTOLEN, a sublingual immunotherapy drug. Torii Pharmaceutical Co., Ltd. markets its products primarily through medical representatives for medical professionals. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Torii Pharmaceutical Co. Ltd has the following listings and related stock indices.


Stock: JPX: 4551 wb_incandescent

Details

Headquarters:

Torii Nihonbashi Building

4-1, Nihonbashi-Honcho 3-chome Chuo-ku

Tokyo, 103-8439

Japan

Phone: 81 3 3231 6811